## WRB: W.R. Berkley Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.8% below STRENGTH zone (3.0-6.0%); PEG 10.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($65.88)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Cresset Asset Management LLC Increases Holdings in W.R. Berkley Corporation $WRB**
- Source: MarketBeat | 20251210T093111 | Somewhat-Bullish | Relevance: 99%
-  Cresset Asset Management LLC significantly increased its stake in W.R. Berkley Corporation by 394.1% in the second quarter, now holding 21,757 shares valued at $1,599,000. Several other institutional investors also adjusted their positions in the insurance provider, demonstrating varied sentiment. Wall Street analysts currently have a "Hold" rating on W.R. Berkley, with an average target price of $74.85, as the company reported strong Q3 earnings and announced a quarterly dividend.

**2. Marshall Wace LLP Decreases Stock Holdings in W.R. Berkley Corporation $WRB**
- Source: MarketBeat | 20251211T110855 | Neutral | Relevance: 99%
-  Marshall Wace LLP significantly reduced its stake in W.R. Berkley Corporation by 76.0% during the second quarter, now holding 178,745 shares valued at $13.13 million. Despite this, other institutional investors like Baird Financial Group Inc., Crestwood Advisors Group LLC, Parallel Advisors LLC, Brooklyn Investment Group, and Checchi Capital Advisers LLC increased their positions in the insurance provider. Analyst ratings for W.R. Berkley are mixed, with an average "Hold" rating and a price target of $74.85, and the company recently announced a quarterly dividend.

**3. WR Berkley (WRB) Falls 14% on Profit-Taking, Investors Digest Mitsui Stake Acquisition**
- Source: Yahoo Finance | 20251209T030957 | Neutral | Relevance: 98%
- WR Berkley (WRB) saw its stock fall by 14.12% last week due to profit-taking by investors and the announcement of Mitsui Sumitomo Insurance Co., Ltd. acquiring a 12.5% stake. The company also declared two cash dividends to common shareholders, a $1 special cash dividend and 9 cents of regular quarterly dividends, both payable on December 29th. The transaction with Mitsui is expected to close in the first quarter of January 2026.

**4. R. Berkley Corporation (WRB): A Bull Case Theory**
- Source: Finviz | 20251209T143600 | Bullish | Relevance: 97%
- This article summarizes a bullish thesis on W.R. Berkley Corporation (WRB), highlighting its disciplined underwriting, decentralized structure, and strong performance despite concerns about its investment portfolio. WRB operates 58 businesses in property and casualty insurance, excelling in underwriting through niche markets and maintaining consistent profitability. The company has outperformed the S&P 500 over the past decade, suggesting it's a high-quality insurer for investors with expertise in specialty insurance.

**5. California Public Employees Retirement System Has $86.49 Million Stock Holdings in W.R. Berkley Corporation $WRB**
- Source: MarketBeat | 20251209T102350 | Somewhat-Bullish | Relevance: 97%
-  The California Public Employees Retirement System reduced its holdings in W.R. Berkley Corporation by 13.9% in the second quarter, now owning 1,177,271 shares valued at $86.49 million. Other institutional investors also adjusted their positions in WRB. The article provides financial data, recent earnings results, dividend announcements, and analyst ratings for the company, noting an average rating of "Hold" with a target price of $74.85.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (-0.6%)
- Blackrock Inc.: 6.5% (-1.8%)
- State Street Corpora: 3.9% (+1.0%)
- Morgan Stanley: 3.1% (-10.8%)
- JPMORGAN CHASE & CO: 2.6% (+35.1%)

### Key Risks

1. Valuation stretched: PEG 10.0x requires aggressive growth execution.
2. Elevated short interest (8.6%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- M&A activity or partnership announcements may unlock value.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 10.02 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 21%). Balance sheet: strong liquidity (2730874000.0x), $1.1B free cash flow. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.4B |
| Beta | 0.38 |
| 52W Range | $55.97 - $78.96 |
| Short Interest | 8.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 10.02 |
| Forward P/E | 14.9 |
| Current P/E | 16.1 |
| YoY Growth | 7.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -11.8% to -1.8% (+10.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.8pp (needs >3.0% for momentum thesis). MRS_5 turning positive (2.8%) - potential reversal signal. Underperforming sector by 3.6pp, stock-specific weakness. Below SMA200 (0.97x), long-term trend not supportive. MACD histogram bearish (-0.88), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.82% (CS: 18) | Neutral |
| RSI_14 | 36.4 | Neutral |
| MACD Histogram | -0.88 | Bearish |
| vs SMA20 | 0.939x | Below |
| vs SMA50 | 0.929x | Below |
| vs SMA200 | 0.971x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $69.34
- **Stop Loss:** $65.88 (5.0% risk)
- **Target:** $72.80 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 398
- **Position Value:** $27,597.32
- **Portfolio %:** 27.60%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-26 (Est: $1.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.10 | $1.10 | -0.2% |
| 2025Q2 | $1.02 | $1.05 | +2.5% |
| 2025Q1 | $0.99 | $1.01 | +2.4% |
| 2024Q4 | $0.95 | $1.13 | +18.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*